4//SEC Filing
OncoMed Pharmaceuticals Inc 4
Accession 0001140361-15-001624
CIK 0001302573operating
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:08 PM ET
Size
4.7 KB
Accession
0001140361-15-001624
Insider Transaction Report
Form 4
Lasky Laurence
Director
Transactions
- Other
Common Stock
2015-01-09+1,449→ 1,449 total
Footnotes (1)
- [F1]The reporting person received the shares for no consideration as part of a pro-rata distribution of shares by funds controlled by Latterell Venture Partners.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001302573
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:08 PM ET
- Size
- 4.7 KB